IGF1 and type 2 diabetes mellitus: Hyperinsulinemia is present in T2D due to insulin resistance, and supraphysiological levels are hypothesized to amplify insulin’s mitogenic effect, both through direct receptor activation and an increase in IGF-1 signaling [40], promoting the proliferation of malignant cells.